STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-05-29
DOI
10.3389/fonc.2019.00436
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combining Tumor Vaccination and Oncolytic Viral Approaches with Checkpoint Inhibitors: Rationale, Pre-Clinical Experience, and Current Clinical Trials in Malignant Melanoma
- (2018) Ludimila Cavalcante et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells
- (2018) Ke Jiang et al. BMC CANCER
- Newcastle disease virus co-expressing interleukin 7 and interleukin 15 modified tumor cells as a vaccine for cancer immunotherapy
- (2018) Xiaojing Xu et al. CANCER SCIENCE
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy
- (2018) Marie-Claude Bourgeois-Daigneault et al. Science Translational Medicine
- Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
- (2018) Adel Samson et al. Science Translational Medicine
- Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies
- (2018) Shashi Gujar et al. OncoImmunology
- PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
- (2018) Dmitriy Zamarin et al. JOURNAL OF CLINICAL INVESTIGATION
- Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives
- (2017) Zong Sheng Guo et al. Frontiers in Immunology
- OPTiM: A randomized phase III trial of talimogene laherparepvec (T-VEC) versus subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment (tx) of unresected stage IIIB/C and IV melanoma.
- (2017) Robert Hans Ingemar Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
- (2016) Robert H. I. Andtbacka et al. ANNALS OF SURGICAL ONCOLOGY
- ΔPK oncolytic activity includes modulation of the tumour cell milieu
- (2016) Dominique Bollino et al. JOURNAL OF GENERAL VIROLOGY
- Oncolytic viruses as immunotherapy: progress and remaining challenges
- (2016) Laure Aurelian OncoTargets and Therapy
- The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells
- (2016) T Colangelo et al. Cell Death & Disease
- STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells
- (2015) Heng Yang et al. CANCER RESEARCH
- Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma
- (2015) Douglas B Johnson et al. Immunotherapy
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Small-molecule targeting of signal transducer and activator of transcription (STAT) 3 to treat non-small cell lung cancer
- (2015) Katherine M. Lewis et al. LUNG CANCER
- Enhancement of the Proapoptotic Properties of Newcastle Disease Virus Promotes Tumor Remission in Syngeneic Murine Cancer Models
- (2015) S. Cuadrado-Castano et al. MOLECULAR CANCER THERAPEUTICS
- Immune checkpoint modulation: Rational design of combination strategies
- (2015) Dmitriy Zamarin et al. PHARMACOLOGY & THERAPEUTICS
- Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner
- (2015) N Werthmöller et al. Cell Death & Disease
- Improvement of immunogenic chemotherapy by STAT3 inhibition
- (2015) Heng Yang et al. OncoImmunology
- CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
- (2015) Zuqiang Liu et al. OncoImmunology
- Trial Watch—Oncolytic viruses and cancer therapy
- (2015) Jonathan Pol et al. OncoImmunology
- Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
- (2015) Ilkka Liikanen et al. OncoImmunology
- Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells
- (2014) Ke Jiang et al. BMC CANCER
- Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapy
- (2014) Fuliang Bai et al. IMMUNOLOGY LETTERS
- High hydrostatic pressure induces immunogenic cell death in human tumor cells
- (2014) Jitka Fucikova et al. INTERNATIONAL JOURNAL OF CANCER
- Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
- (2014) Carolien A. Koks et al. INTERNATIONAL JOURNAL OF CANCER
- ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses
- (2014) Abhishek D. Garg et al. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set
- (2014) Abdul Qader Sukkurwala et al. OncoImmunology
- ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death
- (2013) Abhishek D. Garg et al. Autophagy
- Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments
- (2013) H Inoue et al. CELL DEATH AND DIFFERENTIATION
- Molecular mechanisms of ATP secretion during immunogenic cell death
- (2013) I Martins et al. CELL DEATH AND DIFFERENTIATION
- Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells
- (2013) Donatella D’Eliseo et al. CELL STRESS & CHAPERONES
- Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
- (2013) D. P. Conrad et al. CLINICAL CANCER RESEARCH
- Oncolytic viruses as therapeutic cancer vaccines
- (2013) David L Bartlett et al. Molecular Cancer
- Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies
- (2013) Samuel T Workenhe et al. MOLECULAR THERAPY
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Activation of a glioma-specific immune response by oncolytic parvovirus Minute Virus of Mice infection
- (2012) S P Grekova et al. CANCER GENE THERAPY
- Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
- (2012) I. Diaconu et al. CANCER RESEARCH
- Circulating nucleosomes and biomarkers of immunogenic cell death as predictive and prognostic markers in cancer patients undergoing cytotoxic therapy
- (2012) Oliver J Stoetzer et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Activation of the human immune system via toll-like receptors by the oncolytic parvovirus H-1
- (2012) Maike Sieben et al. INTERNATIONAL JOURNAL OF CANCER
- Involvement of STAT3 in immune evasion during lung tumorigenesis
- (2012) Hiroshi Kida et al. OncoImmunology
- Critical Involvement of Extracellular ATP Acting on P2RX7 Purinergic Receptors in Photoreceptor Cell Death
- (2011) Shoji Notomi et al. AMERICAN JOURNAL OF PATHOLOGY
- Caspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus
- (2011) Jianchun Bian et al. ARCHIVES OF VIROLOGY
- Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor
- (2011) M. S. Redell et al. BLOOD
- Measles virus causes immunogenic cell death in human melanoma
- (2011) O G Donnelly et al. GENE THERAPY
- CD91-dependent programming of T-helper cell responses following heat shock protein immunization
- (2011) Sudesh Pawaria et al. Nature Communications
- Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
- (2010) L. Zitvogel et al. CLINICAL CANCER RESEARCH
- The Oncolytic Activity of Newcastle Disease Virus NDV-HUJ on Chemoresistant Primary Melanoma Cells Is Dependent on the Proapoptotic Activity of the Inhibitor of Apoptosis Protein Livin
- (2009) I. Lazar et al. JOURNAL OF VIROLOGY
- Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus
- (2009) Byram W Bridle et al. MOLECULAR THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now